Treatment of extranodal NK/T-cell lymphoma: From past to future

Extranodal NK/T-cell lymphoma (ENKTCL) is the most common subtype of T/NK-cell lymphoma in Asia and Latin America, but very rare in North American and Europe. Patient survival has improved significantly over the past two decades. However, standard treatment has not yet been established, although doz...

Full description

Bibliographic Details

Published in:	Frontiers in Immunology
Main Authors:	Zheng Yan, Shuna Yao, Zhizhong Wang, Wenping Zhou, Zhihua Yao, Yanyan Liu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-02-01
Subjects:	extranodal NK/T-cell lymphoma asparaginase PD-1/PD-L1 inhibitor immunotherapy treatment novel drug
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1088685/full